⌘K
Loading ticker…
As of 2026-08-24, Compass Therapeutics, Inc. Common Stock (CMPX) has a 3-month relative strength percentile of 76 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 42. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.2%, relative volume 0.28×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CMPX is held by 17 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $3M.
Held by 38 ETFs · $82M across latest filings · largest weight 0.27% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| $111K |
| −0.01 pp |
| GSSC | 0.01% | $111K | new |
| OMFS | 0.02% | $66K | −0.01 pp |
| VTHRVanguard Russell 3000 ETF | 0.00% | $26K | — |
| WSML | 0.00% | $16K | new |
Showing 10 of 17 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CMPX Jan avg: 26.03% median: 1.26% win: 50% σ: 66.47% n: 4 2022-04-12 → 2026-07-31 | CMPX Feb avg: 2.50% median: -7.59% win: 25% σ: 23.11% n: 4 2022-04-12 → 2026-07-31 | CMPX Mar avg: -10.84% median: -10.05% win: 25% σ: 18.93% n: 4 2022-04-12 → 2026-07-31 | CMPX Apr avg: -20.50% median: -7.95% win: 20% σ: 28.02% n: 5 2022-04-12 → 2026-07-31 | CMPX May avg: 29.54% median: 12.90% win: 60% σ: 45.45% n: 5 2022-04-12 → 2026-07-31 | CMPX Jun avg: -3.34% median: -7.98% win: 40% σ: 20.53% n: 5 2022-04-12 → 2026-07-31 | CMPX Jul avg: -1.44% median: -1.89% win: 40% σ: 10.76% n: 5 2022-04-12 → 2026-07-31 | CMPX Aug avg: 14.46% median: 11.64% win: 75% σ: 30.05% n: 4 2022-04-12 → 2026-07-31 (current) | CMPX Sep avg: -3.95% median: -7.58% win: 50% σ: 15.70% n: 4 2022-04-12 → 2026-07-31 | CMPX Oct avg: 6.49% median: -0.89% win: 50% σ: 22.81% n: 4 2022-04-12 → 2026-07-31 | CMPX Nov avg: 19.05% median: 14.73% win: 50% σ: 29.19% n: 4 2022-04-12 → 2026-07-31 | CMPX Dec avg: -0.38% median: -6.43% win: 25% σ: 15.35% n: 4 2022-04-12 → 2026-07-31 |